Metronomic Chemotherapy With Capecitabine for Pancreatic Cancer

Clinical trial NCT03959150 · UNKNOWN

Trial details

NCT number: NCT03959150
Sponsor: Ruijin Hospital
Status: UNKNOWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Pancreatic Cancer

Start date: 2020-01-05
Primary completion: 2022-06-30
Enrollment: 231

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.